Peter Penson on one way to cut the NHS drugs budget

In recent months, the media has reported numerous cases of patients campaigning to be given expensive anti-cancer drugs such as Herceptin by the NHS despite a lack of NICE approval. Difficult decisions must be made about how money should be spent and where economies can be made.

You need to be an HSJ subscriber to read more


Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to
  • The HSJ app

Enquire about multi-user access